Immunovant (IMVT) News Today → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free IMVT Stock Alerts $25.39 -1.02 (-3.86%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 2 at 3:58 AM | americanbankingnews.comImmunovant, Inc. (NASDAQ:IMVT) Given Consensus Recommendation of "Buy" by AnalystsJune 2 at 2:46 AM | americanbankingnews.comImmunovant, Inc. (NASDAQ:IMVT) to Post Q1 2026 Earnings of ($0.62) Per Share, HC Wainwright ForecastsJune 2 at 2:46 AM | americanbankingnews.comImmunovant, Inc. to Post FY2025 Earnings of ($1.73) Per Share, Lifesci Capital Forecasts (NASDAQ:IMVT)June 1 at 5:26 AM | americanbankingnews.comImmunovant (NASDAQ:IMVT) Rating Reiterated by Cantor FitzgeraldJune 1 at 4:32 AM | americanbankingnews.comHC Wainwright Reiterates "Buy" Rating for Immunovant (NASDAQ:IMVT)May 31 at 8:58 AM | marketbeat.comAnalysts Offer Predictions for Immunovant, Inc.'s Q1 2026 Earnings (NASDAQ:IMVT)Immunovant, Inc. (NASDAQ:IMVT - Free Report) - HC Wainwright issued their Q1 2026 earnings per share estimates for Immunovant in a report issued on Thursday, May 30th. HC Wainwright analyst D. Tsao expects that the company will post earnings of ($0.62) per share for the quarter. HC Wainwright curMay 31 at 7:34 AM | americanbankingnews.comImmunovant (NASDAQ:IMVT) Announces Quarterly Earnings ResultsMay 31 at 1:58 AM | americanbankingnews.comRevolution Medicines (NASDAQ:RVMD) vs. Immunovant (NASDAQ:IMVT) Head to Head ContrastMay 31 at 1:24 AM | americanbankingnews.comImmunovant (NASDAQ:IMVT) Shares Gap Down After Earnings MissMay 30 at 12:19 PM | marketbeat.comImmunovant (NASDAQ:IMVT) Earns Overweight Rating from Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating on shares of Immunovant in a research report on Thursday.May 30 at 8:29 AM | marketbeat.comImmunovant (NASDAQ:IMVT) Issues Earnings ResultsImmunovant (NASDAQ:IMVT - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.44) by ($0.08). During the same quarter in the prior year, the business posted ($0.46) EPS.May 29, 2024 | marketbeat.comMonashee Investment Management LLC Sells 100,000 Shares of Immunovant, Inc. (NASDAQ:IMVT)Monashee Investment Management LLC lessened its position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 58.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 70,000 shares of the company's stockMay 29, 2024 | globenewswire.comImmunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024May 29, 2024 | markets.businessinsider.comBiohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage StudyMay 29, 2024 | marketbeat.comImmunovant (NASDAQ:IMVT) Shares Gap Up to $28.42Immunovant (NASDAQ:IMVT) Shares Gap Up to $28.42May 29, 2024 | investing.comImmunovant (IMVT) Earnings Dates & ReportsMay 28, 2024 | marketbeat.com539,097 Shares in Immunovant, Inc. (NASDAQ:IMVT) Bought by Franklin Resources Inc.Franklin Resources Inc. purchased a new position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 539,097 shares of the company's stock, valued at approximately $22,71May 27, 2024 | americanbankingnews.comJulia G. Butchko Sells 3,247 Shares of Immunovant, Inc. (NASDAQ:IMVT) StockMay 27, 2024 | americanbankingnews.comInsider Selling: Immunovant, Inc. (NASDAQ:IMVT) CEO Sells $479,232.95 in StockMay 27, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Increases Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT)Charles Schwab Investment Management Inc. raised its position in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 12.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 437,080 shares of the company's stock after bMay 26, 2024 | americanbankingnews.comEva Renee Barnett Sells 4,042 Shares of Immunovant, Inc. (NASDAQ:IMVT) StockMay 25, 2024 | insidertrades.comInsider Selling: Immunovant, Inc. (NASDAQ:IMVT) Insider Sells 3,247 Shares of StockMay 22, 2024 | marketbeat.comPrincipal Financial Group Inc. Grows Stock Position in Immunovant, Inc. (NASDAQ:IMVT)Principal Financial Group Inc. boosted its position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 34.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 440,115 shares of the company's stock afteMay 20, 2024 | marketbeat.comSwiss National Bank Sells 29,500 Shares of Immunovant, Inc. (NASDAQ:IMVT)Swiss National Bank lowered its position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 22.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 99,600 shares of the company's stock after selling 29,500 shares during the quarter. Swiss National BMay 19, 2024 | morningstar.comImmunovant Inc IMVTMay 17, 2024 | marketbeat.comEFG Asset Management North America Corp. Takes Position in Immunovant, Inc. (NASDAQ:IMVT)EFG Asset Management North America Corp. bought a new position in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 27,005 shares of the company's stock, valued at approximately $1,138,000. AMay 15, 2024 | marketbeat.comNicholas Investment Partners LP Sells 241,845 Shares of Immunovant, Inc. (NASDAQ:IMVT)Nicholas Investment Partners LP reduced its stake in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 64.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 136,310 shares of the company's stock after selMay 12, 2024 | marketbeat.comVictory Capital Management Inc. Reduces Stock Position in Immunovant, Inc. (NASDAQ:IMVT)Victory Capital Management Inc. lowered its stake in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 12.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 325,534 shares ofMay 8, 2024 | marketbeat.comRussell Investments Group Ltd. Acquires 136,418 Shares of Immunovant, Inc. (NASDAQ:IMVT)Russell Investments Group Ltd. raised its stake in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 337.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 176,901 sharesMay 7, 2024 | seekingalpha.comargenx: Innovation Over Losses In Autoimmune ArenaMay 7, 2024 | finance.yahoo.comZacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and LigandMay 7, 2024 | marketbeat.comImmunovant, Inc. (NASDAQ:IMVT) Shares Sold by Federated Hermes Inc.Federated Hermes Inc. lessened its position in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 99.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,979 shares of the company's stock after selling 356,609 shares during the quarApril 28, 2024 | investing.comImmunovant CTO sells shares worth over $209k to cover taxesApril 27, 2024 | insidertrades.comImmunovant, Inc. (NASDAQ:IMVT) Insider Sells $94,242.90 in StockApril 27, 2024 | insidertrades.comImmunovant, Inc. (NASDAQ:IMVT) CTO Sells $209,207.10 in StockApril 26, 2024 | marketbeat.comabrdn plc Makes New $13.81 Million Investment in Immunovant, Inc. (NASDAQ:IMVT)abrdn plc purchased a new position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 327,706 shares of the company's stock, valued at approximately $13,806,0April 24, 2024 | finance.yahoo.comShould You Hold Immunovant (IMVT)?April 23, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Acquires 36,659 Shares of Immunovant, Inc. (NASDAQ:IMVT)Allspring Global Investments Holdings LLC increased its holdings in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 590.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 42,865 shares of the company's stoApril 22, 2024 | markets.businessinsider.comBuy Rating Affirmed for Immunovant on Strong Drug Development Prospects and Efficacy ConfidenceApril 21, 2024 | insidertrades.comJulia G. Butchko Sells 10,115 Shares of Immunovant, Inc. (NASDAQ:IMVT) StockApril 20, 2024 | investing.comImmunovant CFO sells shares worth over $350kApril 19, 2024 | marketbeat.comImmunovant, Inc. (NASDAQ:IMVT) Insider Sells $293,941.90 in StockImmunovant, Inc. (NASDAQ:IMVT - Get Free Report) insider Julia G. Butchko sold 10,115 shares of the business's stock in a transaction dated Wednesday, April 17th. The shares were sold at an average price of $29.06, for a total transaction of $293,941.90. Following the transaction, the insider now owns 451,627 shares in the company, valued at approximately $13,124,280.62. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.April 17, 2024 | marketbeat.comImmunovant (NASDAQ:IMVT) Trading Down 3.6%Immunovant (NASDAQ:IMVT) Trading Down 3.6%April 16, 2024 | finance.yahoo.comImmunovant, Inc. (IMVT) Stock Historical Prices & Data - Yahoo FinanceApril 15, 2024 | marketbeat.comWCM Investment Management LLC Takes $4.55 Million Position in Immunovant, Inc. (NASDAQ:IMVT)WCM Investment Management LLC acquired a new stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 107,401 shares of the company's stock, valued at apprApril 15, 2024 | nasdaq.comImmunovant is Now Oversold (IMVT)April 12, 2024 | investing.comImmunovant CEO sells over $149,000 in company stockApril 11, 2024 | marketbeat.comImmunovant, Inc. (NASDAQ:IMVT) Expected to Post Q1 2026 Earnings of ($0.49) Per ShareImmunovant, Inc. (NASDAQ:IMVT - Free Report) - Stock analysts at Zacks Research dropped their Q1 2026 earnings per share (EPS) estimates for Immunovant in a research note issued on Monday, April 8th. Zacks Research analyst E. Bagri now anticipates that the company will post earnings per share ofApril 11, 2024 | insidertrades.comImmunovant, Inc. (NASDAQ:IMVT) Insider Julia G. Butchko Sells 1,053 SharesApril 10, 2024 | marketbeat.comJulia G. Butchko Sells 1,053 Shares of Immunovant, Inc. (NASDAQ:IMVT) StockImmunovant, Inc. (NASDAQ:IMVT - Get Free Report) insider Julia G. Butchko sold 1,053 shares of the business's stock in a transaction that occurred on Tuesday, April 9th. The stock was sold at an average price of $31.18, for a total value of $32,832.54. Following the completion of the transaction, the insider now owns 461,742 shares in the company, valued at approximately $14,397,115.56. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Get Immunovant News Delivered to You Automatically Sign up to receive the latest news and ratings for IMVT and its competitors with MarketBeat's FREE daily newsletter. Email Address The only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral. Stream the documentary for free by clicking here IMVT Media Mentions By Week IMVT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMVT News Sentiment▼0.580.76▲Average Medical News Sentiment IMVT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMVT Articles This Week▼305▲IMVT Articles Average Week Get Immunovant News Delivered to You Automatically Sign up to receive the latest news and ratings for IMVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CRSP News Today IBRX News Today KRYS News Today SWTX News Today HALO News Today ACLX News Today IOVA News Today APGE News Today DNLI News Today UTZ News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMVT) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunovant, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
